The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population-Reference-Cited by-同舟云学术

The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population

Published:2016-03 Issue:2 Volume:10 Page:289-298
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Yang Moon Hee,Sung Jidong^ORCID,Gwak Geum-Youn

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference42 articles.

1. Non-alcoholic fatty liver disease;Smith;Crit Rev Clin Lab Sci,2011

2. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground;Chitturi;J Gastroenterol Hepatol,2011

3. Prevalence of nonalcoholic Fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994;Lazo;Am J Epidemiol,2013

4. Epidemiology and natural history of NAFLD and NASH;Ong;Clin Liver Dis,2007

5. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease;Qureshi;World J Gastroenterol,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis;World Journal of Clinical Cases;2024-09-06

3. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome;European Cardiology Review;2024-05-09

4. Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?;International Journal of Molecular Sciences;2024-02-06

5. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder;Current Drug Therapy;2024-02